流動性関節炎工場, 良質を買う流動性関節炎製品中国から

N-メチル-N-((3R,4R) -4メチルピペリジン-3-イル) -7H-ピロロ[2,3-d]ピリミジン-4-アミン (477600-74-1)

This compound is mainly used for synthesis of Tofacitinib as intermediate B2. Product Name: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 477600-74-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C13H19N5 Molecular Weight: 245.33 Shelf Life: 2 Years Package: 25kg/drum

トファシチニブシトラート (540737-29-9)

Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C22H28N6O8 Molecular Weight: 504.50 Shelf Life: 2 Years Package: 25kg/drum

4-クロロ-7H-ピロロ[2,3-d]ピリミジン (3680-69-1)

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in organic synthesis. In the synthesis of Tofacitinib, it is used as intermediate. Product Name: 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 3680-69-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C6H4ClN3 Molecular Weight: 153.57 Shelf Life: 2 Years Package: 25kg/drum

(3R,4R)-1-ベンジル-N,4-ジメチルピペリジン-3-アミン二酸化塩化物 (1062580-52-2)

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride can be used as organic synthesis intermediates and pharmaceutical intermediates, for instance intermediate A for Tofacitinib. Product Name: (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS No.: 1062580-52-2 Assay: 98% End Use: Tofacitinib Molecular Formula: C14H23ClN2 Molecular Weight: 254.8 Shelf Life: 2 Years Package: 25kg/drum

N-((3R,4R)-1-ベンジル-4-メチルピペリジン-3-イル) -N-メチル-7-トシル-7H-ピロロ[2,3-d]ピリミジン-4-アミン (923036-30-0)

This compound is mainly used for synthesis of Tofacitinib as intermediate. Product Name: N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 923036-30-0 Assay: 98% End Use: Tofacitinib Molecular Formula: C27H31N5O2S Molecular Weight: 489.64 Shelf Life: 2 Years Package: 25kg/drum

エトラシモド (1206123-37-6)

Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of adult patients with moderately to severely active ulcerative colitis. It can partially reversibly block the outflow of lymphocytes and reduce the number of lymphocytes in the peripheral blood, thereby reducing the migration of lymphocytes into the intestine and exerting a therapeutic effect. Product Name: Etrasimod CAS No.: 1206123-37-6 Assay: 99% Specification: CP, EP,

エチル2-(7-ヒドロキシ-1,2,3,4-テトラヒドロサイクロペンタ[b]インドル-3-イール) アセテート (1206124-13-1)

Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate is an intermediate of Etrasimod. Product Name: Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS No.: 1206124-13-1 Assay: 98% End Use: Etrasimod Molecular Formula: C15H17NO3 Molecular Weight: 259.3 Shelf Life: 2 Years Package: 25kg/drum

塩化メチル-1-サイクロペンチル-2-トリフルーロメチルベンゼン (957208-65-0)

4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene is an intermediate of Etrasimod. Product Name: 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene CAS No.: 957208-65-0 Assay: 98% End Use: Etrasimod Molecular Formula: C13H14ClF3 Molecular Weight: 262.7 Shelf Life: 2 Years Package: 25kg/drum

1−""エトキシエチル"−4−4"4,55テトラメチル-132 ダイオキサボロラン-2-イール) 1H-ピラゾール (1029716-44-6)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib, also for other compounds. Product Name: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole CAS No.: 1029716-44-6 Assay: 98% End Use: Baricitinib Molecular Formula: C13H23BN2O3 Molecular Weight: 266.15 Shelf Life: 2 Years Package: 25kg/drum

2-(1-(エチルサルフォニル) アゼチジン-3-イリデン) アセトニトリル (1187595-85-2)

Baricitinib intermediate 2 is an intermediate for synthesis of Baricitinib. Product Name: 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitril CAS No.: 1187595-85-2 Assay: 98% End Use: Baricitinib Molecular Formula: C7H10N2O2S Molecular Weight: 186.23 Shelf Life: 2 Years Package: 25kg/drum

(1h-ピラゾール-4-イール)-7-((2-(トリメチルシリル)エトキシ)メチル)-7h-ピロロ[2,3-d]ピリミジン (941685-27-4)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib. Product Name: (1h-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7h-pyrrolo[2,3-d]pyrimidine CAS No.: 941685-27-4 Assay: 98% End Use: Baricitinib Molecular Formula: C15H21N5O Molecular Weight: 315.45 Shelf Life: 2 Years Package: 25kg/drum

バリシチニブ・フォスファート (1187595-84-1)

Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising treatment for rheumatoid arthritis. Product Name: Baricitinib Phosphate CAS No.: 1187595-84-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C16H20N7O6PS Molecular Weight: 469.41 Shelf Life: 2 Years Package: 25kg/drum

N-(4-(2-アミノアセチル) -5-メトキシ-2-フェノキシフェニル) メタネスルフォンナミド水素化物 149436-41-9

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(4-(2-Aminoacetyl)-5-Methoxy-2-Phenoxyphenyl) MethanesulfonamideHydrochloride CAS No.: 149436-41-9 Assay: 98% End Use: Ellamod Molecular Formula: C16H19ClN2O5S Molecular Weight: 386.85 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag

N- ((5-メトキシ-2-フェノキシフェニル) メタネスルフォナミド 123664-84-6

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide CAS No.: 123664-84-6 Assay: 98% End Use: Ellamod Molecular Formula: C14H15NO4S Molecular Weight: 293.34 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag

流動性 関節 炎

流動性関節炎